This post was originally published on this site
BERLIN (Reuters) – Switzerland signed a contract to buy Pfizer (NYSE:PFE)’s anti-viral drug Paxlovid to treat Covid-19, it said on Friday.
The European country said it had signed a contract to buy 12,000 packages and first treatments for certain at-risk patients would start this month.
